首页> 外国专利> Heteroaryl compounds which inhibit leukocyte adhesion mediated by Integrin alpha 4

Heteroaryl compounds which inhibit leukocyte adhesion mediated by Integrin alpha 4

机译:抑制由整合素α4介导的白细胞粘附的杂芳基化合物

摘要

Described are compounds that bind to Integrin alpha4 Integrin alpha 4, where is preferably vla-4. Some of these compounds can also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by Integrin alpha4 Integrin alpha 4, where is preferably vla-4.These compounds are useful in the treatment of inflammatory diseases in a Mammalian patient, e.g., Human, such as Asthma, Alzheimer's disease, atherosclerosis, Dementia caused by AIDS, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant Tissues, tumor metastasis and Myocardial Ischemia.The compounds can also be administered for the treatment of inflammatory Brain diseases such as multiple sclerosis.Claim 1: a compound of formula (1), in which each X is independently, Fluorine, Chlorine or Bromine, p is an integer of 0 OR 1 - 3; r1 is selected from the group consisting of methyl and Ethyl; R2 is selected from the Group comprising Lower alkyl, alquenilo Lower, and alquilencicloalquilo Bottom; and their salts are acceptable for pharmaceutical use.
机译:描述了与整联蛋白α4结合的化合物整联蛋白α4,其中优选为vla-4。这些化合物中的一些还可以抑制白细胞粘附,特别是由整合素α4整合素α4介导的白细胞粘附,其中优选vla-4。这些化合物可用于治疗哺乳动物患者的炎性疾病,例如人, AIDS,糖尿病,炎性肠病,类风湿性关节炎,移植组织,肿瘤转移和心肌缺血等引起的哮喘,阿尔茨海默氏病,动脉粥样硬化,痴呆等化合物也可用于治疗炎症性脑疾病如多发性硬化症。权利要求1:式(1)的化合物,其中每个X独立地是氟,氯或溴,p是0或1-3的整数; r1选自甲基和乙基; R 2选自低级烷基,alquenilo低级和alquilencicloalquilo底部;及其盐类可用于制药。

著录项

  • 公开/公告号AR042047A1

    专利类型

  • 公开/公告日2005-06-08

    原文格式PDF

  • 申请/专利权人 ELAN PHARMACEUTICALS INC.;

    申请/专利号AR2003P104211

  • 发明设计人

    申请日2003-11-14

  • 分类号C07D239/50;A61K31/505;A61P7/02;A61P19/02;A61P25/28;A61P29/00;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号